Is zoryve a jak inhibitor?

Yes. Zoryve is a topical JAK inhibitor. Its active ingredient is ruxolitinib, which inhibits the JAK1 and JAK2 enzymes to reduce inflammatory signaling. It’s approved for topical use in certain inflammatory skin conditions (notably plaque psoriasis in adults, with specific age indications depending on the region).

If you’d like, I can pull up the exact labeling for your country or give details on dosing, indications, and safety.